223 related articles for article (PubMed ID: 25277097)
1. Role of soluble epoxide hydrolase in age-related vascular cognitive decline.
Nelson JW; Young JM; Borkar RN; Woltjer RL; Quinn JF; Silbert LC; Grafe MR; Alkayed NJ
Prostaglandins Other Lipid Mediat; 2014 Oct; 113-115():30-7. PubMed ID: 25277097
[TBL] [Abstract][Full Text] [Related]
2. Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury.
Strauss KI; Gruzdev A; Zeldin DC
Prostaglandins Other Lipid Mediat; 2013; 104-105():18-24. PubMed ID: 22922090
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.
Koerner IP; Jacks R; DeBarber AE; Koop D; Mao P; Grant DF; Alkayed NJ
J Neurosci; 2007 Apr; 27(17):4642-9. PubMed ID: 17460077
[TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
Zhang W; Otsuka T; Sugo N; Ardeshiri A; Alhadid YK; Iliff JJ; DeBarber AE; Koop DR; Alkayed NJ
Stroke; 2008 Jul; 39(7):2073-8. PubMed ID: 18369166
[TBL] [Abstract][Full Text] [Related]
5. Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia.
Zhang W; Iliff JJ; Campbell CJ; Wang RK; Hurn PD; Alkayed NJ
J Cereb Blood Flow Metab; 2009 Aug; 29(8):1475-81. PubMed ID: 19471280
[TBL] [Abstract][Full Text] [Related]
6. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism.
Marowsky A; Burgener J; Falck JR; Fritschy JM; Arand M
Neuroscience; 2009 Oct; 163(2):646-61. PubMed ID: 19540314
[TBL] [Abstract][Full Text] [Related]
7. Increased Soluble Epoxide Hydrolase in Human Gestational Tissues from Pregnancies Complicated by Acute Chorioamnionitis.
Hung TH; Chen SF; Wu CH; Kao CC; Wu CP
Mediators Inflamm; 2019; 2019():8687120. PubMed ID: 31885501
[TBL] [Abstract][Full Text] [Related]
8. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling.
Merkel MJ; Liu L; Cao Z; Packwood W; Young J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H679-87. PubMed ID: 20008276
[TBL] [Abstract][Full Text] [Related]
10. A novel role for P450 eicosanoids in the neurogenic control of cerebral blood flow in the rat.
Iliff JJ; Close LN; Selden NR; Alkayed NJ
Exp Physiol; 2007 Jul; 92(4):653-8. PubMed ID: 17639071
[TBL] [Abstract][Full Text] [Related]
11. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
[TBL] [Abstract][Full Text] [Related]
12. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.
Dalle Vedove F; Fava C; Jiang H; Zanconato G; Quilley J; Brunelli M; Guglielmi V; Vattemi G; Minuz P
J Hypertens; 2016 Jul; 34(7):1364-70. PubMed ID: 27115337
[TBL] [Abstract][Full Text] [Related]
13. Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy.
Chen G; Xu R; Wang Y; Wang P; Zhao G; Xu X; Gruzdev A; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E563-75. PubMed ID: 22739108
[TBL] [Abstract][Full Text] [Related]
14. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
[TBL] [Abstract][Full Text] [Related]
15. Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids.
Marowsky A; Meyer I; Erismann-Ebner K; Pellegrini G; Mule N; Arand M
Arch Toxicol; 2017 Nov; 91(11):3571-3585. PubMed ID: 28975360
[TBL] [Abstract][Full Text] [Related]
16. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
[TBL] [Abstract][Full Text] [Related]
17. Soluble epoxide hydrolase: gene structure, expression and deletion.
Harris TR; Hammock BD
Gene; 2013 Sep; 526(2):61-74. PubMed ID: 23701967
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in soluble epoxide hydrolase: association with outcome after aneurysmal subarachnoid hemorrhage.
Martini RP; Ward J; Siler DA; Eastman JM; Nelson JW; Borkar RN; Alkayed NJ; Dogan A; Cetas JS
J Neurosurg; 2014 Dec; 121(6):1359-66. PubMed ID: 25216066
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling.
Liu Y; Webb HK; Fukushima H; Micheli J; Markova S; Olson JL; Kroetz DL
J Pharmacol Exp Ther; 2012 Jun; 341(3):725-34. PubMed ID: 22414856
[TBL] [Abstract][Full Text] [Related]
20. Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels.
Fang X; Weintraub NL; McCaw RB; Hu S; Harmon SD; Rice JB; Hammock BD; Spector AA
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2412-20. PubMed ID: 15284062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
